David A. Dichek

7.2k total citations · 1 hit paper
120 papers, 5.8k citations indexed

About

David A. Dichek is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, David A. Dichek has authored 120 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 44 papers in Genetics and 37 papers in Cancer Research. Recurrent topics in David A. Dichek's work include Protease and Inhibitor Mechanisms (33 papers), Virus-based gene therapy research (32 papers) and RNA Interference and Gene Delivery (23 papers). David A. Dichek is often cited by papers focused on Protease and Inhibitor Mechanisms (33 papers), Virus-based gene therapy research (32 papers) and RNA Interference and Gene Delivery (23 papers). David A. Dichek collaborates with scholars based in United States, United Kingdom and Belgium. David A. Dichek's co-authors include Renu Virmani, Andrew H. Schulick, Kurt D. Newman, Thomas Quertermous, Darren B. Schneider, Mary Beth DeYoung, Jeffrey J. Rade, Andrew D. Frutkin, Peter G. Stock and Zhonghua Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David A. Dichek

118 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries

2009 470 citations David A. Dichek et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Dichek United States	42	2.8k	1.6k	1.4k	984	944	120	5.8k
Suzanne M. Watt United Kingdom	46	2.8k 1.0×	341 0.2×	1.3k 0.9×	495 0.5×	1.2k 1.3×	145	6.6k
Roberta Mazzieri Australia	29	2.7k 1.0×	792 0.5×	286 0.2×	1.3k 1.4×	1.3k 1.4×	60	5.2k
Barbara Ferris United States	28	2.4k 0.8×	711 0.4×	456 0.3×	687 0.7×	705 0.7×	39	4.6k
Bi‐Sen Ding United States	37	2.9k 1.0×	220 0.1×	1.2k 0.9×	770 0.8×	896 0.9×	74	6.4k
Franck Verrecchia France	40	3.4k 1.2×	441 0.3×	600 0.4×	816 0.8×	718 0.8×	99	6.2k
Torsten Tonn Germany	46	2.9k 1.1×	704 0.4×	2.9k 2.1×	374 0.4×	3.6k 3.8×	162	9.7k
Jerry Ware United States	50	2.0k 0.7×	800 0.5×	1.1k 0.8×	460 0.5×	1.4k 1.5×	148	8.4k
Philippe Leboulch United States	43	3.8k 1.3×	1.8k 1.1×	1.1k 0.8×	426 0.4×	337 0.4×	113	5.9k
V.E. Koteliansky Russia	35	2.1k 0.8×	312 0.2×	457 0.3×	670 0.7×	375 0.4×	65	4.4k
Wolf‐Karsten Hofmann Germany	42	2.9k 1.0×	238 0.1×	735 0.5×	805 0.8×	1.1k 1.2×	251	6.7k

Countries citing papers authored by David A. Dichek

Since Specialization

Citations

This map shows the geographic impact of David A. Dichek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Dichek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Dichek more than expected).

Fields of papers citing papers by David A. Dichek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Dichek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Dichek. The network helps show where David A. Dichek may publish in the future.

Co-authorship network of co-authors of David A. Dichek

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Dichek. A scholar is included among the top collaborators of David A. Dichek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Dichek. David A. Dichek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daugherty, Alan, Dianna M. Milewicz, David A. Dichek, et al.. (2025). Recommendations for Design, Execution, and Reporting of Studies on Experimental Thoracic Aortopathy in Preclinical Models. Arteriosclerosis Thrombosis and Vascular Biology. 45(5). 609–631.

Stamatikos, Alexis, Nagadhara Dronadula, Philip Ng, et al.. (2018). ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation. Human Gene Therapy. 30(2). 236–248. 50 indexed citations

Wacker, Bradley K., Lianxiang Bi, & David A. Dichek. (2018). <em>In Vivo</em> Gene Transfer to the Rabbit Common Carotid Artery Endothelium. Journal of Visualized Experiments. 3 indexed citations

Bi, Lianxiang, Bradley K. Wacker, & David A. Dichek. (2018). A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts. Journal of Visualized Experiments. 1 indexed citations

Pamir, Nathalie, Patrick M. Hutchins, Graziella E. Ronsein, et al.. (2017). Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight. 2(15). 36 indexed citations

Jiang, Bo, Liang Du, Rowan Flynn, et al.. (2012). Overexpression of Endothelial Nitric Oxide Synthase Improves Endothelium-Dependent Vasodilation in Arteries Infused with Helper-Dependent Adenovirus. Human Gene Therapy. 23(11). 1166–1175. 4 indexed citations

Flynn, Rowan, Kun Qian, Chongren Tang, et al.. (2011). Expression of Apolipoprotein A-I in Rabbit Carotid Endothelium Protects Against Atherosclerosis. Molecular Therapy. 19(10). 1833–1841. 28 indexed citations

Dronadula, Nagadhara, Li‐Lin Du, Ryan A. Flynn, et al.. (2010). Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels. Gene Therapy. 18(5). 501–508. 14 indexed citations

Flynn, Rowan, et al.. (2010). Helper-dependent Adenoviral Vectors are Superior In Vitro to First-generation Vectors for Endothelial Cell-targeted Gene Therapy. Molecular Therapy. 18(12). 2121–2129. 19 indexed citations

10.

Cozen, Aaron E., Hideaki Moriwaki, Mary Beth DeYoung, et al.. (2004). Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death. Circulation. 109(17). 2129–2135. 77 indexed citations

11.

Wen, Shan, et al.. (2000). Second-Generation Adenoviral Vectors Do Not Prevent Rapid Loss of Transgene Expression and Vector DNA From the Arterial Wall. Arteriosclerosis Thrombosis and Vascular Biology. 20(6). 1452–1458. 45 indexed citations

12.

Véniant, Murielle M., Constance Zlot, Rosemary L. Walzem, et al.. (1998). Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.. Journal of Clinical Investigation. 102(8). 1559–1568. 122 indexed citations

13.

Schulick, Andrew H., Giuseppe Vassalli, Patrick F. Dunn, et al.. (1997). Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.. Journal of Clinical Investigation. 99(2). 209–219. 119 indexed citations

14.

Taylor, Allen J., David A. Dichek, Gang Dong, et al.. (1997). Regional Variability in the Time Course of TGF-β1 Expression, Cellular Proliferation and Extracellular Matrix Expansion following Arterial Injury. Growth Factors. 14(4). 297–306. 15 indexed citations

15.

Newman, Kurt D., Patrick F. Dunn, Andrew H. Schulick, et al.. (1995). Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.. Journal of Clinical Investigation. 96(6). 2955–2965. 259 indexed citations

16.

Rome, Jonathan J., et al.. (1995). 996-8 In Vivo Adenovirus-Mediated Gene Transfer via the Pulmonary Artery of Rats. Journal of the American College of Cardiology. 25(2). 323A–323A. 2 indexed citations

17.

Lee, Sung W., Mark L. Kahn, & David A. Dichek. (1993). Control of clot lysis by gene transfer. Trends in Cardiovascular Medicine. 3(2). 61–66. 5 indexed citations

18.

Jaklitsch, Michael T., Sadatoshi Biro, Ward Casscells, & David A. Dichek. (1993). Transduced endothelial cells expressing high levels of tissue plasminogen activator have an unaltered phenotype in vitro. Journal of Cellular Physiology. 154(1). 207–216. 12 indexed citations

19.

Dichek, David A. & Thomas Quertermous. (1989). Variability in messenger RNA levels in human umbilical vein endothelial cells of different lineage and time in culture. In Vitro Cellular & Developmental Biology - Plant. 25(3). 289–292. 36 indexed citations

20.

Dichek, David A., Godtfred Holmvang, John T. Fallon, et al.. (1988). Angiosarcoma of the heart: Three-year survival and follow-up by nuclear magnetic resonance imaging. American Heart Journal. 115(6). 1323–1324. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact